Kang Yu Mi - Div Endocrinol & Metab, Univ Ulsan

基本信息

浏览量：70

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 75 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Comparative Efficacy and Tolerability of Currently Approved Incretin Mimetics: A Systematic Analysis of Placebo-Controlled Clinical Trials

Yu Mi Kang, Viktoria Punov,Soo Lim, Michael A Nauck

Diabetes, obesity & metabolismno. 7 (2025): 3736-3746

引用0浏览0WOS引用

Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations with or Without Type 2 Diabetes And/or Overweight or Obesity

Matthew M Y Lee,Nazim Ghouri,Anoop Misra,Yu Mi Kang,Martin K Rutter, Hertzel C Gerstein,Darren K McGuire,Naveed Sattar

Diabetes careno. 3 (2025): 489-493

引用0浏览0WOS引用

Design and Rationale of the CORE-TIMI 72a and CORE2-TIMI 72b Trials of Olezarsen in Patients with Severe Hypertriglyceridemia

Nicholas A Marston,Brian A Bergmark,Veronica J Alexander,Ewa Karwatowska-Prokopczuk,Yu Mi Kang,Filipe A Moura,Thomas A Prohaska,Andre Zimerman, Shuanglu Zhang,Sabina A Murphy,Sotirios Tsimikas,Robert P Giugliano,Marc S Sabatine

American heart journal (2025): 125-135

引用0浏览0WOS引用

The Contemporary Landscape of Cardiovascular Optimization in Type 2 Diabetes: Overcoming Barriers to Evidence-Based Use of Newer Antihyperglycemic Agents

Kareem Malas, Salman Kazmi,Yu Mi Kang, Darren K McGuire

Expert opinion on pharmacotherapypp.1-12, (2025)

引用0浏览0WOS引用

Olezarsen in Patients with Hypertriglyceridemia at High Cardiovascular Risk: Rationale and Design of the Essence-TIMI 73b Trial

Brian A Bergmark,Nicholas A Marston,Thomas A Prohaska,Veronica J Alexander,Andre Zimerman,Filipe A Moura,Yu Mi Kang,Sabina A Murphy, Shuanglu Zhang,Michael T Lu,Ewa Karwatowska-Prokopczuk,Sotirios Tsimikas,Robert P Giugliano,Marc S Sabatine

American heart journal (2025): 116-124

引用0浏览0WOS引用

Glucagon-like Peptide-1 Receptor Agonists Lower Risk of Cardiovascular and Non-Cardiovascular Mortality: A Meta-Analysis of Eleven Cardiovascular Outcome Trials

Yu Mi Kang,Erin A Bohula,A Michael Lincoff, Donna H Ryan, KyungAh Im, Colleen Thomas, Marc S Sabatine, Benjamin M Scirica

Diabetes, obesity & metabolismno. 7 (2025): 4017-4021

引用0浏览0WOS引用

SGLT2 INHIBITORS AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES AT HIGH RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, HEART FAILURE OR CHRONIC KIDNEY DISEASE: A SMART-C COLLABORATIVE META-ANALYSIS

Siddharth M. Patel,Yu Mi Kang,KyungAh Im,Brendon Neuen,Hiddo Lambers Heerspink,Marc Steven Sabatine,Stephen Wiviott

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGYno. 13 (2024): 1904-1904

引用0浏览0引用

Functional Characterization of Plant Specific Indeterminate Domain (IDD) Transcription Factors in Tomato (solanum Lycopersicum L.)

Sujeevan Rajendran,Yu Mi Kang, In Been Yang, Hye Bhin Eo, Kyung Lyung Baek,Seonghoe Jang, Assaf Eybishitz,Ho Cheol Kim,Byeong Il Je,Soon Ju Park,Chul Min Kim

SCIENTIFIC REPORTSno. 1 (2024)

引用2浏览0WOSNATURE引用

Is This the Real Life? Real-World Evidence of Empagliflozin in Health Care Resource Utilization and Cost

Josephine Harrington,Yu Mi Kang,Darren K McGuire

Diabetes careno. 11 (2024): 1897-1899

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn